Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05621733
What this trial is testing

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

Who this might be right for
Graft-versus-Host Disease
Novartis Pharmaceuticals 140
Testing effectiveness (Phase 2)Looking for participantsNCT04282187
What this trial is testing

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Acute Myeloid LeukemiaEssential ThrombocythemiaMyelodysplastic Syndrome+6 more
University of Washington 25
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT05127421
What this trial is testing

Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement

Who this might be right for
Atopic Dermatitis
Incyte Corporation 77
Testing effectiveness (Phase 2)Study completedNCT01787487
What this trial is testing

Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiableMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+1 more
M.D. Anderson Cancer Center 121
Testing effectiveness (Phase 2)Study completedNCT02809976
What this trial is testing

Topical Ruxolitinib for the Treatment of Vitiligo

Who this might be right for
Vitiligo
Tufts Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06973668
What this trial is testing

Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease

Who this might be right for
AML
M.D. Anderson Cancer Center 80
Early research (Phase 1)UnknownNCT04303403
What this trial is testing

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

Who this might be right for
Colorectal CancerPancreatic Adenocarcinoma
National Cancer Centre, Singapore 48
Testing effectiveness (Phase 2)Study completedNCT04669210
What this trial is testing

PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT

Who this might be right for
Graft-versus-host-diseaseStem Cell Transplant ComplicationsAcute Myeloid Leukemia+1 more
St. Petersburg State Pavlov Medical University 128
Early research (Phase 1)Looking for participantsNCT06008808
What this trial is testing

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseGraft Versus Host Disease
Washington University School of Medicine 41
Large-scale testing (Phase 3)Study completedNCT02101268
What this trial is testing

Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF

Who this might be right for
Primary Myelofibrosis (PMF)Post-polycythemia Vera (Post-PV)Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Sierra Oncology LLC - a GSK company 156
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Testing effectiveness (Phase 2)Study completedNCT04403243
What this trial is testing

COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19

Who this might be right for
COVID 19
Lomonosov Moscow State University Medical Research and Educational Center 70
Testing effectiveness (Phase 2)Study completedNCT02723994
What this trial is testing

Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Incyte Corporation 171
Testing effectiveness (Phase 2)Looking for participantsNCT07359859
What this trial is testing

Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00674479
What this trial is testing

INCB018424 in Patients With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 51
Not applicableNo Longer AvailableNCT04355793
What this trial is testing

Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection

Who this might be right for
COVID-19
Incyte Corporation
Large-scale testing (Phase 3)Looking for participantsNCT04116502
What this trial is testing

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

Who this might be right for
Polycythemia Vera
University of Birmingham 586
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783412
What this trial is testing

Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Oregon Health and Science University 12
Large-scale testing (Phase 3)Study completedNCT04530344
What this trial is testing

Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo

Who this might be right for
Vitiligo
Incyte Corporation 458
Next Page